We are live on
!
Find out more
NCM
Nantahala Capital Management Portfolio holdings
AUM
$2.72B
1-Year Est. Return
121.58%
This Fund
S&P 500
This Quarter
Est. Return
+19.64%
1 Year Est. Return
+121.58%
3 Year Est. Return
+308.64%
5 Year Est. Return
+308.9%
10 Year Est. Return
+2,888.73%
AUM
$2.47B
AUM Growth
+$251M
(+11%)
Cap. Flow
-$37.4M
Cap. Flow
% of AUM
-1.51%
Top 10 Holdings %
Top 10 Hldgs %
47.29%
Holding
93
New
13
Increased
28
Reduced
15
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
World Acceptance Corp
WRLD
|
+$14.4M |
| 2 |
Iovance Biotherapeutics
IOVA
|
+$12.1M |
| 3 |
Akebia Therapeutics
AKBA
|
+$11.4M |
| 4 |
XELA
Exela Technologies, Inc. Common Stock
XELA
|
+$10.2M |
| 5 |
ZVO
Zovio Inc. Common Stock
ZVO
|
+$9.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIGA Technologies
SIGA
|
+$23M |
| 2 |
CGNT
Cogentix Medical, Inc.
CGNT
|
+$14M |
| 3 |
AGS
PlayAGS
AGS
|
+$9.28M |
| 4 |
uniQure
QURE
|
+$2.67M |
| 5 |
Tenet Healthcare
THC
|
+$1.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.02% |
| 2 | Financials | 8.26% |
| 3 | Industrials | 6.87% |
| 4 | Technology | 5.75% |
| 5 | Consumer Discretionary | 5.69% |
Similar funds
TAM
FNF
CA
XL
NB
MASUI
PA
BCM
Nantahala Capital Management's Q2 2018 Portfolio in Review
As of Q2 2018, Nantahala Capital Management held 93 positions worth $2.47B, up 11% from $2.22B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Nantahala Capital Management's Q2 2018 filing shows 13 new, 28 increased, 15 reduced and 4 closed positions. Its largest new stake was Iovance Biotherapeutics: 825,000 shares worth $10.6M. The largest sale was SIGA Technologies, an estimated $23M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
- Nantahala Capital Management's largest Q2 2018 buy was Iovance Biotherapeutics: 825,000 shares worth $10.6M.
- Nantahala Capital Management added most to World Acceptance Corp in Q2 2018, an estimated $14.4M increase.
- Nantahala Capital Management's biggest Q2 2018 reduction was SIGA Technologies, cutting an estimated $23M.
- Nantahala Capital Management fully exited Cogentix Medical, Inc. in Q2 2018, selling an estimated $14M.
- Nantahala Capital Management's ten largest holdings make up 47% of its $2.47B portfolio in Q2 2018.
- Nantahala Capital Management opened 13 new positions and closed 4 in Q2 2018.
- Nantahala Capital Management's portfolio value rose 11% quarter-over-quarter to $2.47B.
Based on Nantahala Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.